H-D-Bip-OH CAS 170080-13-4 - Manufacturers, Suppliers, Factory from China

H-D-Bip-OH CAS 170080-13-4, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

H-D-Bip-OH CAS 170080-13-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-D-Bip-OH CAS 170080-13-4 D-4,4'-Biphenylalanine Purity >98.0% (HPLC) e.e >98.0%
Read More

H-D-Bip-OH CAS 170080-13-4 D-4,4′-Biphenylalanine Purity >98.0% (HPLC) e.e >98.0%

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...

2022.08.02 16:36:28
2022.07.16 20:44:39
2022.06.13 11:05:29
2022.03.13 03:21:05
2022.02.12 14:47:01
2022.01.22 06:20:05

H-D-Bip-OH CAS 170080-13-4 - Manufacturers, Suppliers, Factory from China

Related Products

H-D-Bip-OH CAS 170080-13-4 D-4,4'-Biphenylalanine Purity >98.0% (HPLC) e.e >98.0%

H-D-Bip-OH CAS 170080-13-4 D-4,4′-Biphenylalanine Purity >98.0% (HPLC) e.e >98.0%

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

4-(p-Tolyl)butyric Acid CAS 4521-22-6 Purity >99.0% (HPLC)

4-Methyl-L-Phenylalanine CAS 1991-87-3 H-Phe(4-Me)-OH Purity >98.0% (T) (HPLC) Factory

2-Cyanopyridine CAS 100-70-9 Purity ≥99.5% (GC) Factory

4-Fluorobenzeneboronic Acid CAS 1765-93-1 Purity ≥99.0% (HPLC) Factory

(R)-(-)-Glycidyl Butyrate CAS 60456-26-0 Purity ≥97.0% (GC) e.e ≥99.0% Factory High Quality

Boc-D-Cyclopropylglycine CAS 609768-49-2 Assay >98.0% (HPLC)

4,4'-Diaminobenzanilide CAS 785-30-8 Purity >99.0% (HPLC)

2,5-Bis(trifluoromethyl)aniline CAS 328-93-8 Purity >99.0% (GC)

2-(Trifluoromethyl)phenothiazine CAS 92-30-8 Purity >98.5% (HPLC) Trifluoperazine Dihydrochloride Intermediate Factory

Boc-β-HoAla-OH CAS 158851-30-0 Boc-L-β-Homoalanine Purity >98.0% (HPLC)

Diphenyl Diselenide CAS 1666-13-3 Purity >98.0% (GC) Factory High Purity

Boc-Asp(OBzl)-OH CAS 7536-58-5 Purity >99.0% (HPLC) Factory

Yellow phosphorus and phosphoric acid rose together

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Paxlovid: what we know about Pfizer's Covid-19 pill

The “Summit on COVID-19 Diagnostics & Treatment”

2022.08.02 16:36:28

2022.07.16 20:44:39

2022.06.13 11:05:29

2022.03.13 03:21:05

2022.02.12 14:47:01

2022.01.22 06:20:05

related search